Elizabeth Morgan is senior vice president of clinical, regulatory and quality operations with more than 30 years of experience in the biotechnology and pharmaceutical industry. She has a proven track record in recruiting, training and managing clinical, regulatory and quality departments through all stages of drug development.
Elizabeth has been involved in the successful filing of more than 25 Investigational New Drug Applications, five New Drug Applications and one pre-market approval. Her recent experience includes New Drug Application and Marketing Authorization Application approval of VABOMERE™ (meropenem and vaborbactam), MINOCIN® (minocycline) for Injection, QUINSAIR® (levofloxacin nebuliser solution) and Dermagraft®. Elizabeth has led inspection-readiness activities, participated in several successful FDA inspections and has held executive positions at The Medicines Company, Rempex Pharmaceuticals, Mpex Pharmaceuticals, Nereus Pharmaceuticals, Hollis Eden and The Immune Response. Prior to that, she held clinical, regulatory and quality positions of increasing responsibility at Advanced Tissue Sciences and Dura Pharmaceuticals.
Elizabeth received her Bachelor of Science in biology from San Diego State University in San Diego, California.
